IP Library Granted Patent US 7,989,639
Granted Patent B2
US 7,989,639 · App. 12/302,576 · Granted Aug 2, 2011

Process for making salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide

Assignee: Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,989,639
App. No.
12/302,576
Granted
Aug 2, 2011
Kind
B2
Abstract

Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide are prepared by various methods.

Claims (38)

1. A method of preparing the lactate monohydrate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide comprising the steps of:

(a) suspending N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide free base monohydrate in acetone;

(b) adding lactic acid dropwise with stirring at ambient temperature, wherein the lactic acid is present in an equimolar amount;

(c) stirring the reaction mixture for a time sufficient to cause precipitation of the lactate monohydrate salt; and

(d) cooling the reaction mixture.

2. The method of claim 1 further comprising the steps of:

(e) isolating the precipitated lactate monohydrate salt of N-hydroxy-3-[4-[[[2-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide;

(f) washing the salt with cold acetone; and

(g) drying the salt.

3. A method of preparing the anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide comprising the steps of:

(a) providing a solution of lactic acid;

(b) suspending N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide free base in water;

(c) heating the suspension to an appropriate temperature;

(d) adding the solution of lactic acid to form a solution;

(e) seeding the solution with a suspension of the anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide;

(f) stirring the solution for a time;

(g) heating the solution to a second appropriate temperature;

(h) stirring the solution for a time;

(i) cooling the solution; and

(j) stirring the solution for a time sufficient to precipitate the anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

4. The method of claim 3 further comprising the steps of:

(k) isolating the precipitated anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide;

(l) washing the salt with water; and

(m) drying the salt.

5. A method of preparing the anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide comprising the steps of:

(a) providing a solution of lactic acid;

(b) suspending N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide free base in a 1:1 mixture of ethanol and water;

(c) heating the suspension to an appropriate temperature;

(d) adding the solution of lactic acid to form a solution;

(e) cooling the solution;

(f) seeding the solution with anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide;

(g) stirring the solution for a time;

(h) cooling the solution; and

(i) stirring the solution for a time sufficient to precipitate the anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

6. The method of claim 5 further comprising the steps of:

(j) isolating the precipitated anhydrous lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide;

(k) washing the salt with water; and

(l) drying the salt.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: SECURA BIO, INC.
To: PHARMA& SCHWEIZ GMBH
Reel/Frame 063992/0870 →
RELEASE OF IP SECURITY INTEREST AT REEL/FRAME 048510/0364 Recorded Oct 31, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SECURA BIO, INC.
Reel/Frame 061814/0821 →
CONFIRMATORY ASSIGNMENT Recorded May 21, 2019
From: NOVARTIS AG
To: SECURA BIO, INC.
Reel/Frame 049246/0720 →
SECURITY INTEREST Recorded Mar 5, 2019
From: SECURA BIO, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048510/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2019
From: NOVARTIS PHARMA AG
To: SECURA BIO, INC.
Reel/Frame 048477/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2011
From: BAJWA, JOGINDER; PARKER, DAVID JOHN; SLADE, JOEL
To: NOVARTIS AG
Reel/Frame 026096/0710 →
Continuity (3)
Provisional Application 60804529 · Jun 12, 2006
Provisional Application 60853259 · Oct 20, 2006
Related Publication 20090187029A1 · Jul 23, 2009